Covaxin set to go global after WHO gives it a booster
Business Standard|November 04, 2021
Becomes sixth vaccine to receive validation
SOHINI DAS

Hyderabad-based Bharat Biotech's vaccine, Covaxin, received the much-awaited Emergency Use Listing (EUL) from the World Health Organization (WHO) on Wednesday, bringing relief to students, business travelers, and all those who intend to travel abroad.

The WHO decided to grant the EUL after a risk-benefit assessment of Covaxin for global use. It said in a tweet: “WHO has granted emergency use listing (EUL) to Covaxin (developed by Bharat Biotech), adding to a growing portfolio of vaccines validated by WHO for the prevention of Covid-19."

"This emergency use listing expands the availability of vaccines, the most effective medical tools we have to end the pandemic," said Dr Mariângela Simão, WHO's assistant director-general for Access to Medicines and Health Products.

This makes Covaxin the sixth vaccine to receive EUL after the Pfizer-BioNTech, AstraZeneca, Johnson & Johnson-Janssen, Moderna, and Sinopharm vaccines.

Continue reading your story on the app

Continue reading your story in the newspaper

MORE STORIES FROM BUSINESS STANDARDView All

Double-digit loan growth may buoy ICICI Bank profit

ICICI Bank is expected to post a healthy profit for the December quarter (Q3FY22), helped by a double-digit growth in loans, when it reports its earnings on Saturday.

1 min read
Business Standard
January 22, 2022

Zomato hits record low, m-cap falls below ₹1trn

Shares of Zomato continued to wilt under selling pressure on Friday, falling 9 per cent on the BSE to ₹113.75, the lowest close since its listing on July 23, 2021.

1 min read
Business Standard
January 22, 2022

Shoppers Stop hits 52-week high

Shares of Shoppers Stop ended 5 per cent higher at ₹378.65 on the BSE on Friday in an otherwise weak market after the company reported a strong operational performance for the December quarter (Q3FY22).

1 min read
Business Standard
January 22, 2022

Separate 5G band & aviation radar frequency: Airtel

Experts say that unlike the US, India already has a large separation between the two bands

2 mins read
Business Standard
January 22, 2022

Pandemic darlings of investors face the boot

Stay-at-home market darling Netflix slumped on Friday, joining a broad decline in the market value of other pandemic favourites this week as investors priced in expectations for a return to normalcy as more countries gradually relax Covid-19 restrictions.

1 min read
Business Standard
January 22, 2022

Tesla Gets An Offer, But With A Caveat

Centre wants a commitment on local manufacturing, while states go all out

2 mins read
Business Standard
January 21, 2022

Offline Retailers Feel Omicron Chill With No Thaw In Sight

Higher discounts might still see muted Republic Day, End-Of-Season sales

3 mins read
Business Standard
January 21, 2022

Indices Slump For Third Straight Day On Inflation Fears

Sensex down 3% in 3 days as bond yields, oil prices rise

2 mins read
Business Standard
January 21, 2022

Early birds hint at subdued earnings growth in Dec qtr

Net profit up 10.4% YoY, growing at slowest pace in five quarters

2 mins read
Business Standard
January 21, 2022

Amazon offers helping hand to cash-strapped Future

Includes solution proposed in term sheet for ₹7,000-crore infusion

2 mins read
Business Standard
January 21, 2022
RELATED STORIES

Health staff, elderly to get 3rd vaccine jab from today

NEW DELHI: High-risk heath and front line workers, and senior citizens with co-morbidities can from today walk into any vaccination centre for inoculation with a third precautionary dose, provided the second dose was taken nine months ago. They can also book a slot online through the government's COWIN portal.

2 mins read
Hindustan Times
January 10, 2022

To boost fight, ‘precaution dose' of vax begins today

‘SMSes Sent to Over 1 Crore Beneficiaries’

1 min read
The Times of India Mumbai
January 10, 2022

The shelf life of vaccines

How long does a vaccine stay potent? This depends on stability tests, and can be extended based on data, as has happened with Covishield and Covaxin. What data are analysed, and how is shelf life determined?

4 mins read
The Indian Express Delhi
January 04, 2022

Experts to get cracking, now

To decide which vaccine is to be given to kids; which vaccine will be the booster dose; and what will be the gap between the last dose and the 'precautionary shot for elderly

2 mins read
The Free Press Journal
December 27, 2021

Vaccine for 15-17 age group, booster for frontline staff

Additional shots also for 60+; regulator clears Covaxin for 12+ group

2 mins read
The New Indian Express
December 26, 2021

PM Modi announces vaccine for children, ‘precaution' dose for health staff, elderly

India logs 415 Omicron cases; Bharat Biotech’s Covaxin gets emergency nod for children aged 12-18

4 mins read
Millennium Post Delhi
Delhi 26 December 2021

NO KIDDING, JAB FOR 12+

Covaxin allowed for emergency use in children above 12 years; decision will go a long way in bringing kids back into the classroom and the playfield. Two more vaccines for children are in the making

2 mins read
The Free Press Journal
December 26, 2021

Young women flag vax 'effects on menstruation

While docs in city dismiss links with Covid vaccines, research finally begins abroad

3 mins read
The New Indian Express
December 14, 2021

Covaxin 50% effective against Covid: Lancet

Authors say vaccine effectiveness of Covaxin estimated in this study is lower than the efficacy reported by recently published phase 3 trial

3 mins read
Millennium Post Delhi
November 25, 2021

Hosps improvise as unused Covid vax doses near expiry

Some Cut Price, Others Give Free Jabs Under CSR

3 mins read
The Times of India Mumbai
November 16, 2021